The effects of PRX-07034, a novel 5-HT6 antagonist, on cognitive flexibility and working memory in rats
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Accumulating evidence indicates that schizophrenia and autism spectrum disorder patients are marked by cognitive deficits in working memory and strategy switching. There is accumulating evidence that 5-hydroxytryptamine (5-HT)6 receptors may serve as a useful target to improve cognitive functioning. In the present experiments, the novel 5-HT6 antagonist, PRX-07034, was examined for its selectivity of the 5-HT6 receptor, as well as its effect on delayed spontaneous alternation and strategy switching. The binding affinity of PRX-07034 to the 5-HT6 receptor, other 5-HT receptors, as well as other G-protein coupled receptors, ion channels, and transporters was evaluated. Cyclic AMP production was measured from transfected HEK-293 cells. In separate behavioral experiments, rats received different doses of PRX-07034 (0.1, 1, or 3 mg/kg, i.p.) 30 min prior to delayed spontaneous alternation testing or prior to the acquisition and switch phases in a place–response switch test. The results indicated that PRX-07034 is both a potent (Ki = 4–8 nM) and highly selective 5-HT6 receptor antagonist (≥100-fold selectivity for the 5-HT6 receptor compared to 68 other GPCRs, ion channels, and transporters, except D3 (Ki = 71 nM) and 5-HT1B (Ki = 260 nM) receptors. For cyclic AMP quantification, PRX-07034 demonstrated antagonist activity (IC50 = 19 nM) without an effect on basal levels and did not show any agonist activity up to 10 μM. PRX-07034 at 1 and 3 mg/kg (but not 0.1 mg/kg) significantly enhanced delayed spontaneous alternation. The drug at 1 and 3 mg/kg also enhanced switching between a place and response strategy, but did not affect initial learning of either a place or response discrimination. These findings demonstrate that PRX-07034 is a selective 5-HT6 receptor antagonist that may represent a novel treatment for enhancing working memory and cognitive flexibility.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dopamine receptors: from structure to function
MISSALE, C., NASH, S. R., ROBINSON, S. W., JABER, M., & CARON, M. G. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.189 · Cited by 3,633
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
Corbett, B. A., Constantine, L. J., Hendren, R., Rocke, D., & Ozonoff, S. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2008.02.005 · Cited by 584
Schumann, C. M., Bloss, C. S., Barnes, C. C., Wideman, G. M., Carper, R. A., Akshoomoff, N., Pierce, K., Hagler, D., Schork, N., Lord, C., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5714-09.2010 · Cited by 554
Chudasama, Y., & Robbins, T. W. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-25-08771.2003 · Cited by 543
Floresco, S. B., Block, A. E., & Tse, M. T. L. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.02.008 · Cited by 405
Multiple dopamine receptor subtypes in the medial prefrontal cortex of the rat regulate set-shifting
Floresco, S. B., Magyar, O., Ghods-Sharifi, S., Vexelman, C., & Tse, M. T. L. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300825 · Cited by 395 · cited 1×
“…the effects of a 5-HT6 receptor antagonist on a strategy-switching test may be particularly relevant because previous studies showed that schizophrenia or autism spectrum disorder subjects have setshifting deficits (Elliot et al. 1995; Pantelis et al. 1999; Jazbec et al. 2007; Corbett et al. 2009).”
BackgroundNeuropsychological evidence for frontostriatal dysfunction in schizophrenia
Elliott, R., McKenna, P. J., Robbins, T. W., & Sahakian, B. J. (1995) · Psychological Medicine · doi:10.1017/s0033291700033523 · Cited by 267
Ragozzino, M. E. (2002) · Learning & Memory · doi:10.1101/lm.45802 · Cited by 174 · cited 2×
“More specifically, several experiments found that lesions or drug infusions into prefrontal cortex subregions selectively affect perseveration, but do not generally affect the learning of a new strategy once selected (Ragozzino et al. 1999, 2003; Ragozzino 2002; Chudasama and Robbins 2003; Kim and Ragozzino 2005; Flor…”
BackgroundSelf-citationRodefer, J. S., Nguyen, T. N., Karlsson, J.-J., & Arnt, J. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301654 · Cited by 126 · cited 3×
“The enhancement is comparable to that observed with SB399885 on a reversal learning test (Hatcher et al. 2005) and SB-271046 which attenuates a PCP-induced impairment in set-shifting (Rodefer et al. 2008).”
BackgroundResult
Cited by
Alzheimer's disease drug development pipeline: 2018
Cummings, J., Lee, G., Ritter, A., & Zhong, K. (2018) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.03.009 · Cited by 697
“Other agents in this class are currently in trials (Suvn502) or have shown efficacy in preclinical models (PRX07034Z) [21].”
BackgroundMiller, H. L., Ragozzino, M. E., Cook, E. H., Sweeney, J. A., & Mosconi, M. W. (2015) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-014-2244-1 · Cited by 131
“…drugs frequently are used to target RRBs in ASD (Veenstra-VanderWeele and Blakely 2011), and preclinical studies have identified multiple 5HT receptor subtypes critically involved in cognitive flexibility in mice (Amodeo et al. 2014; Brown et al. 2012; Baker et al. 2011; Mohler et al. 2012).”
BackgroundSelf-citation5HT6 antagonists in the treatment of Alzheimer's dementia: current progress
Andrews, M., Tousi, B., & Sabbagh, M. N. (2018) · Neurology and Therapy · doi:10.1007/s40120-018-0095-y · Cited by 50
Metadata
- Authors
- Mohler, E. G., Baker, P. M., Gannon, K. S., Jones, S. S., Shacham, S., Sweeney, J. A., & Ragozzino, M. E.
- Venue
- Psychopharmacology
- Published
- 2011-10-12
- Volume
- 220
- Issue
- 4
- Pages
- 687-696
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W1964717274
- Cited by
- 46
- References
- 10
- FWCI
- 1.07
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The effects of PRX-07034, a novel 5-HT6 antagonist, on cognitive flexibility and working memory in rats. https://app.cochat.ai/papers/10.1007/s00213-011-2518-7
- The paper
- Mohler, E. G., Baker, P. M., Gannon, K. S., Jones, S. S., Shacham, S., Sweeney, J. A., & Ragozzino, M. E. (2012). The effects of PRX-07034, a novel 5-HT6 antagonist, on cognitive flexibility and working memory in rats. Psychopharmacology. https://doi.org/10.1007/s00213-011-2518-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.